No abstract available
MeSH terms
-
Anti-Inflammatory Agents / therapeutic use
-
Betacoronavirus*
-
COVID-19
-
COVID-19 Drug Treatment
-
Cell Cycle Proteins / antagonists & inhibitors
-
Coronavirus Infections / drug therapy*
-
Coronavirus Infections / immunology
-
Coronavirus Infections / virology
-
Cytokines / metabolism*
-
Host Microbial Interactions / drug effects
-
Host Microbial Interactions / immunology
-
Humans
-
Immunologic Factors / therapeutic use
-
Inflammasomes / drug effects
-
Inflammasomes / immunology
-
Inflammation / drug therapy*
-
Inflammation / immunology
-
Inflammation / virology
-
Interleukin-6 / antagonists & inhibitors
-
Models, Immunological
-
NLR Family, Pyrin Domain-Containing 3 Protein / antagonists & inhibitors
-
Pandemics
-
Pneumonia, Viral / drug therapy*
-
Pneumonia, Viral / immunology
-
Pneumonia, Viral / virology
-
SARS-CoV-2
-
Transcription Factors / antagonists & inhibitors
Substances
-
Anti-Inflammatory Agents
-
BRD4 protein, human
-
Cell Cycle Proteins
-
Cytokines
-
IL6 protein, human
-
Immunologic Factors
-
Inflammasomes
-
Interleukin-6
-
NLR Family, Pyrin Domain-Containing 3 Protein
-
NLRP3 protein, human
-
Transcription Factors